Humacyte, Inc. (HUMA) Reports In-Line Q4 EPS

Humacyte, Inc. (NASDAQ: HUMA) reported Q4 EPS of ($0.24), in-line with the analyst estimate of ($0.24).

For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Southland Holdings (SLND) Misses Q2 EPS by 122c
• Aptera Motors (SEV) Reports Q2 Loss of $0.20